Cutler Group LP Gilead Sciences, Inc. Transaction History

Cutler Group LP

$307 Million
Q1 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$62.32 - $89.47 $1.29 Million - $1.85 Million	-20,717 Reduced 50.18%	20,570 $1.77 Million
Q3 2022 Oct 25, 2022	BUY	$59.54 - $68.01 $1.71 Million - $1.95 Million	28,681 Added 227.52%	41,287 $2.55 Million
Q2 2022 Aug 04, 2022	SELL	$57.72 - $65.01 $1.64 Million - $1.85 Million	-28,433 Reduced 69.28%	12,606 $779,000
Q1 2022 Apr 14, 2022	BUY	$57.92 - $72.58 $2.11 Million - $2.64 Million	36,353 Added 775.78%	41,039 $2.44 Million
Q4 2021 Jan 18, 2022	BUY	$64.88 - $73.64 $149,159 - $169,298	2,299 Added 96.31%	4,686 $340,000
Q1 2021 Apr 26, 2021	SELL	$60.0 - $68.46 $1.91 Million - $2.18 Million	-31,799 Reduced 93.02%	2,387 $154,000
Q4 2020 Jan 21, 2021	BUY	$56.65 - $64.55 $5,665 - $6,455	100 Added 0.29%	34,186 $1.99 Million
Q3 2020 Oct 27, 2020	SELL	$62.1 - $78.08 $452,336 - $568,734	-7,284 Reduced 17.61%	34,086 $2.15 Million
Q2 2020 Jul 22, 2020	BUY	$72.34 - $84.0 $443,588 - $515,088	6,132 Added 17.4%	41,370 $3.18 Million
Q1 2020 May 07, 2020	BUY	$62.63 - $80.22 $1.68 Million - $2.15 Million	26,802 Added 317.71%	35,238 $2.63 Million
Q4 2019 Feb 06, 2020	BUY	$61.62 - $67.78 $215,670 - $237,230	3,500 Added 70.91%	8,436 $548,000
Q3 2019 Oct 28, 2019	SELL	$62.51 - $69.0 $316,488 - $349,347	-5,063 Reduced 50.64%	4,936 $312,000
Q2 2019 Aug 09, 2019	SELL	$61.87 - $69.38 $419,478 - $470,396	-6,780 Reduced 40.41%	9,999 $675,000
Q1 2019 May 10, 2019	SELL	$62.53 - $70.05 $634,616 - $710,937	-10,149 Reduced 37.69%	16,779 $1.09 Million
Q4 2018 Feb 05, 2019	SELL	$60.54 - $79.0 $700,084 - $913,556	-11,564 Reduced 30.04%	26,928 $1.68 Million
Q3 2018 Nov 07, 2018	BUY	$71.28 - $78.92 $16,822 - $18,625	236 Added 0.62%	38,492 $2.97 Million
Q2 2018 Aug 10, 2018	BUY	$64.88 - $75.68 $594,560 - $693,531	9,164 Added 31.5%	38,256 $2.71 Million
Q1 2018 May 11, 2018	SELL	$72.84 - $88.8 $892,581 - $1.09 Million	-12,254 Reduced 29.64%	29,092 $2.19 Million
Q4 2017 Jan 17, 2018	BUY	$71.15 - $83.52 $620,926 - $728,879	8,727 Added 26.75%	41,346 $2.96 Million
Q3 2017 Oct 17, 2017	BUY	$72.11 - $85.47 $2.35 Million - $2.79 Million	32,619	32,619 $2.64 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account